Since
the first discovery of its ibuprofen-like anti-inflammatory
activity in 2005, the olive phenolic (−)-oleocanthal gained
great scientific interest and popularity due to its reported health
benefits. (−)-Oleocanthal is a monophenolic secoiridoid exclusively
occurring in extra-virgin olive oil (EVOO). While several groups have
investigated oleocanthal pharmacokinetics (PK) and disposition, none
was able to detect oleocanthal in biological fluids or identify its
PK profile that is essential for translational research studies. Besides,
oleocanthal could not be detected following its addition to any fluid
containing amino acids or proteins such as plasma or culture media,
which could be attributed to its unique structure with two highly
reactive aldehyde groups. Here, we demonstrate that oleocanthal spontaneously
reacts with amino acids, with high preferential reactivity to glycine
compared to other amino acids or proteins, affording two products:
an unusual glycine derivative with a tetrahydropyridinium skeleton
that is named oleoglycine, and our collective data supported the plausible
formation of tyrosol acetate as the second product. Extensive studies
were performed to validate and confirm oleocanthal reactivity, which
were followed by PK disposition studies in mice, as well as cell culture
transport studies to determine the ability of the formed derivatives
to cross physiological barriers such as the blood-brain barrier. To
the best of our knowledge, we are showing for the first time that
(-)-oleocanthal
is biochemically transformed to novel products in amino acids/glycine-containing
fluids, which were successfully monitored in vitro and in vivo, creating a completely new perspective
to understand the well-documented bioactivities of oleocanthal in
humans.